Caxton Associates (New York)’s Duck Creek Technologies, Inc. Common Stock DCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-14,217
Closed -$211K 722
2022
Q2
$211K Buy
+14,217
New +$250K 0.02% 457

Other funds holding DCT

Caxton Associates (New York)'s DCT Position: Q3 2022 in Review

Caxton Associates (New York) sold out of Duck Creek Technologies, Inc. Common Stock (DCT) in Q3 2022, closing a stake of 14,217 shares — an estimated $211K sold.

Caxton Associates (New York) first reported a position in DCT in Q2 2022 and held it in 1 quarter. The position peaked at $211K in Q2 2022. 173 funds tracked by Wall St. Rank hold DCT as of Q3 2022.

  • Caxton Associates (New York) reported no remaining Duck Creek Technologies, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Caxton Associates (New York) sold 14,217 Duck Creek Technologies, Inc. Common Stock shares in Q3 2022, an estimated $211K.
  • Caxton Associates (New York) first reported a position in Duck Creek Technologies, Inc. Common Stock in Q2 2022 and held it in 1 quarter.
  • Caxton Associates (New York)'s Duck Creek Technologies, Inc. Common Stock position peaked at $211K in Q2 2022.
  • 173 funds tracked by Wall St. Rank held Duck Creek Technologies, Inc. Common Stock as of Q3 2022.

Based on Caxton Associates (New York)'s 13F filing for Q3 2022, filed 14 Nov 2022.